Pfizer hikes full-year outlook as Q2 results top estimates; shares up

Pfizer (PFE) PT Raised to $34 at Goldman Sachs

July 31, 2024 5:20 AM EDT

Goldman Sachs analyst Chris Shibutani raised the price target on Pfizer (NYSE: PFE) to $34.00 (from $31.00) while maintaining a Buy rating.

The analyst comments "Relative outperformance on the day (+2% vs. flat XLV) appears warranted in our view given solid 2Q results... More

Pfizer, JetBlue, PayPal rise premarket; Merck, CrowdStrike, Diageo fall

July 30, 2024 7:33 AM EDT

Investing.com -- U.S. stock futures edged higher Tuesday, in cautious trade ahead of the start of the latest Federal reserve meeting, and with the quarterly earnings season in full flow.

Here are some of the biggest premarket U.S. stock movers today

Merck (NYSE: MRK) stock fell 1.6% after the drugs company cut its full-year earnings forecast mainly due to one-time charges from its acquisition of eye-focused drug developer EyeBio.

... More

Pfizer lifts profit forecast as investors await turnaround

July 30, 2024 6:51 AM EDT

By Michael Erman and Bhanvi Satija

(Reuters) - Pfizer raised its annual profit forecast on Tuesday, helped by cancer treatments acquired through a $43 billion deal for Seagen and strong sales of its heart disease drug as the company deals with a sharp revenue drop from COVID products.

The market for Pfizer's COVID-19 vaccine and treatment has shrunk by billions of dollars a year.

Pfizer CEO Albert Bourla responded with several acquisitions, including the Seagen deal and cost-cutting measures. The New York-based drugmaker also has sharpened its focus on cancer treatments.

Investors fled from Pfizer as... More

Pfizer (PFE) Tops Q2 EPS by 14c; raises guidance

July 30, 2024 6:47 AM EDT

Pfizer (NYSE: PFE) reported Q2 EPS of $0.60, $0.14 better than the analyst estimate of $0.46. Revenue for the quarter came in at $13.3 billion versus the consensus estimate of $13.03 billion.

GUIDANCE:

Pfizer sees FY2024 EPS of $2.45-$2.65, versus the consensus of $2.38. Pfizer now... More

Fed meeting, Microsoft earns, BP dividend - what's moving markets

July 30, 2024 5:31 AM EDT

Investing.com -- The Federal Reserve starts its latest policy-setting meeting, while investors look forward to more corporate earnings, particularly from the important tech sector. BP has already impressed with its second-quarter numbers. 

1. Fed starts policy-setting meeting 

The Federal Reserve starts its July policy meeting later in the session, and after a benign June inflation report, investors after looking for the policymakers to lay the groundwork for a September rate cut.

... More

Stocks expected to have increasing option volume: PFE PYPL IT SYY GLW SOFI JBLU FFIV SFM

July 30, 2024 4:50 AM EDT

Stocks expected to have increasing option volume: PFE PYPL IT SYY GLW SOFI JBLU FFIV SFM

... More

Pfizer (PFE) call put ratio 1.7 calls to 1 put into quarter results

July 29, 2024 11:26 AM EDT

Pfizer (NYSE: PFE) August weekly call option implied volatility is at 58, August is at 33; compared to its 52-week range of 19 to 34 into expected release of quarter results before the bell on July 30.

... More

Pfizer (PFE) call put ratio 2.3 calls to 1 put into quarter results

July 29, 2024 5:31 AM EDT

Pfizer (NYSE: PFE) August 2 weekly 31 straddle priced for a move of 4% into expected release of quarter results before the bell on July 30.

... More

Popular stocks with increasing volume: GME F PFE COIN PLTR SMCI MMM CMG CRWD AVGO

July 29, 2024 5:17 AM EDT

Popular stocks with increasing volume: GME F PFE COIN PLTR SMCI MMM CMG CRWD AVGO

... More